Skip to content

Biomarkers In Retinitis Pigmentosa (BIRP)

Biomarkers In Retinitis Pigmentosa (BIRP)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01949623
Acronym
BIRP
Enrollment
100
Registered
2013-09-24
Start date
2013-09-30
Completion date
2017-07-31
Last updated
2017-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa

Keywords

RP

Brief summary

In this study, markers of oxidative stress will be measured in the aqueous humour and plasma of RP patients compared to controls.

Detailed description

People with Retinitis Pigmentosa have loss of night vision followed by loss of central vision due to damage and death of photoreceptors. One of the mechanisms causing damage is high levels of oxygen in the eye. This damage produces specific biomarkers which can be measured. In this study, these biomarkers will be assessed in people with Retinitis Pigmentosa and compared to controls.

Interventions

Aqueous Samples will be collected for measurement of biomarkers

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Signed informed consent and authorization of use and disclosure of protected health information * Age more than or equal to 18 years * For the study group, patients diagnosed with Retinitis Pigmentosa by the investigators * For the control group, patients undergoing vitreoretinal surgery for macular hole, epiretinal membrane, vitreomacular traction, retinal detachment, neovascular Age-related Macular Degeneration (AMD) and Diabetic Retinopathy will be eligible

Exclusion criteria

* Patients with active or suspected ocular or periocular infection

Design outcomes

Primary

MeasureTime frame
Aqueous levels of markers of oxidative stress in patients with RP and controls.2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026